أعرض في EDS

Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study

التفاصيل البيبلوغرافية
العنوان:	Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study
المؤلفون:	Winsley Rose, Reshma Raju, Sudhir Babji, Anna George, Ramya Madhavan, Julian Vivek Leander Xavier, Jenita Sharon David Chelladurai, Origanti Sharon Nikitha, Arpitha Anbu Deborah, Shalini Vijayakumar, Sushil Immanuel, Jacob John, Priscilla Rupali, Kundavaram P.P. Abhilash, Venkata Raghava Mohan, Karthik Bharadwaj Tallapaka, Prasanna Samuel, Gagandeep Kang
المصدر:	The Lancet Regional Health - Southeast Asia. 12:100141
بيانات النشر:	Elsevier BV, 2023.
سنة النشر:	2023
تدمد:	2772-3682
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::7cec11d34c7eb63219ed97e99899b101 https://doi.org/10.1016/j.lansea.2023.100141
حقوق:	OPEN
رقم الأكسشن:	edsair.doi...........7cec11d34c7eb63219ed97e99899b101
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	27723682